Reply to the letter to the editor 'The ESMO magnitude of clinical benefit scaling tool: From theory to practice' by Hartmann and the letter 'Comment on ESMO magnitude of clinical benefit scale' by Muhonen et al.

N. I. Cherny, R. Sullivan, U. Dafni, J. M. Kerst, A. Sobrero, C. Zielinski, E. G E De Vries, M. J. Piccart

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)203-205
Number of pages3
JournalAnnals of Oncology
Issue number1
Publication statusPublished - Jan 1 2016

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this